Enteral Formula Tolerance of Standard Tube Feedings
1 other identifier
observational
102
2 countries
3
Brief Summary
This prospective observational study seeks to assess ability to achieve enteral feeding goals with standard tube feeding formulas.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2014
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
December 5, 2014
CompletedFirst Posted
Study publicly available on registry
December 9, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedMay 31, 2017
May 1, 2017
2.2 years
December 5, 2014
May 29, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Daily percentage of caloric nutritional goal met
21 days
Secondary Outcomes (3)
Daily percentage of protein goal met
21 days
GI tolerance
21 days
Adverse events and serious adverse events
21 days
Study Arms (1)
enterally fed adults
adult subjects with established enteral access receiving standard tube feeding formula
Interventions
Eligibility Criteria
Adults with established enteral access receiving standard tube feeding formula
You may qualify if:
- ≥18 years of age
- Currently tolerating enteral feeding
- Has enteral access
- Requires enteral tube feeding to provide 90% or more of their nutritional needs (without the use of modular(s)) for at least 21 days
- Having obtained his/her and/or his/her legal representative's informed consent.
You may not qualify if:
- Condition which contraindicates enteral feeding (i.e. intestinal obstruction)
- Lack of enteral access
- Any condition that would contraindicate use of the study product (i.e. need for severe fluid restriction, cow's milk protein allergy, other)
- Currently participating in another conflicting clinical study that would interfere with anticipated endpoints
- Judged to be at risk for poor compliance to the study protocol.
- Lack of informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
University of Arkansas
Little Rock, Arkansas, United States
Vanderbilt University
Nashville, Tennessee, United States
Bruyere Research Institute
Ottawa, Ontario, Canada
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 5, 2014
First Posted
December 9, 2014
Study Start
December 1, 2014
Primary Completion
March 1, 2017
Study Completion
April 1, 2017
Last Updated
May 31, 2017
Record last verified: 2017-05